Half-Dose Valcyte for 1 Month in CMV Intermediate Risk Kidney Transplant Recipients… A Cost-Effective Alternative?
2019 ◽
Vol 19
(3)
◽
pp. 68
2019 ◽
Vol 17
(3)
◽
pp. 339-343
◽
2015 ◽
Vol 30
(suppl_3)
◽
pp. iii366-iii366
2018 ◽
Vol 26
(4)
◽
pp. 232-238
◽
Keyword(s):
2016 ◽
Vol 31
(suppl_1)
◽
pp. i568-i568